The influence of acetylator phenotype on the outcome of treatment with phenelzine, in a clinical trial. 1978

E F Marshall, and C Q Mountjoy, and I C Campbell, and R F Garside, and I M Leitch, and M Roth

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D009497 Neurotic Disorders Disorders in which the symptoms are distressing to the individual and recognized by him or her as being unacceptable. Social relationships may be greatly affected but usually remain within acceptable limits. The disturbance is relatively enduring or recurrent without treatment. Neuroses,Psychoneuroses,Disorder, Neurotic,Disorders, Neurotic,Neurotic Disorder
D010624 Phenelzine One of the MONOAMINE OXIDASE INHIBITORS used to treat DEPRESSION; PHOBIC DISORDERS; and PANIC. Fenelzin,2-Phenethylhydrazine,Nardelzine,Nardil,Phenelzine Sulfate,Phenethylhydrazine,beta-Phenylethylhydrazine,2 Phenethylhydrazine,Sulfate, Phenelzine,beta Phenylethylhydrazine
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000107 Acetylation Formation of an acetyl derivative. (Stedman, 25th ed) Acetylations
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

E F Marshall, and C Q Mountjoy, and I C Campbell, and R F Garside, and I M Leitch, and M Roth
September 1982, The British journal of psychiatry : the journal of mental science,
E F Marshall, and C Q Mountjoy, and I C Campbell, and R F Garside, and I M Leitch, and M Roth
January 1965, Clinical pharmacology and therapeutics,
E F Marshall, and C Q Mountjoy, and I C Campbell, and R F Garside, and I M Leitch, and M Roth
December 1981, Neuropharmacology,
E F Marshall, and C Q Mountjoy, and I C Campbell, and R F Garside, and I M Leitch, and M Roth
May 1979, British journal of clinical pharmacology,
E F Marshall, and C Q Mountjoy, and I C Campbell, and R F Garside, and I M Leitch, and M Roth
April 1985, International journal of clinical pharmacology, therapy, and toxicology,
E F Marshall, and C Q Mountjoy, and I C Campbell, and R F Garside, and I M Leitch, and M Roth
November 1979, Psychological medicine,
E F Marshall, and C Q Mountjoy, and I C Campbell, and R F Garside, and I M Leitch, and M Roth
August 1981, British journal of clinical pharmacology,
E F Marshall, and C Q Mountjoy, and I C Campbell, and R F Garside, and I M Leitch, and M Roth
January 1982, European journal of clinical pharmacology,
E F Marshall, and C Q Mountjoy, and I C Campbell, and R F Garside, and I M Leitch, and M Roth
September 1997, Leprosy review,
E F Marshall, and C Q Mountjoy, and I C Campbell, and R F Garside, and I M Leitch, and M Roth
January 1984, The Netherlands journal of medicine,
Copied contents to your clipboard!